Inhaler app developer to use funds to launch new products

04/5/2013 | MobiHealthNews.com

Asthmapolis, a Madison, Wis.-based developer of an inhaler sensor and application for patients with respiratory illnesses such as cystic fibrosis and asthma, has successfully raised $5 million from a recent funding round led by venture fund The Social+Capital Partnership. The investment will be used to introduce new sensors that suit various kinds of inhaled medications, as well to make sure the product is available to people at all socioeconomic levels.

View Full Article in:

MobiHealthNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI